Utah Retirement Systems Mersana Therapeutics, Inc. Transaction History

Utah Retirement Systems

  • $8.85 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$15.31 - $26.52 $463,586 - $803,025
-30,280 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$16.84 - $27.59 $10,508 - $17,216
-624 Reduced 2.02%
30,280 $806,000
Q3 2020

Nov 16, 2020
BUY
$16.2 - $25.7 $500,644 - $794,232
30,904 New
30,904 $575,000

Others Institutions Holding MRSN

# of Institutions
130
Shares Held
104M
Call Options Held
58.5K
Put Options Held
471K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $56.4M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Utah Retirement Systems Portfolio

Follow Utah Retirement Systems and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email